Medication reference
Atropine
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- atropine
Source ID
H51-920FFC12C4B68479CDD1ADCA - Generic name
- Atropine
Source ID
H51-D772F077326FFBC2C803F602 - Class
- Cardiovascular and vasoactive
Source ID
H51-91DB86569C5DB3CEA013C4A7 - Subclass
- Antimuscarinic
Source ID
H51-F65FF3AC679FC61670213835 - Primary uses
- Symptomatic bradycardia
Source ID
H51-35CC4A63A23EE81190C39804 - Organophosphate/carbamate poisoning
Source ID
H51-E1C78AE871B082FB18381A35
- Symptomatic bradycardia
- Mechanism
- Competitively blocks muscarinic acetylcholine receptors and reduces parasympathetic cardiac effects.
Source ID
H51-72A6BA0355334CC92475B0A1 - Mechanism level
- drug_specific
Source ID
H51-E9BA516C22D499A915AD0676 - Basic dosing orientation
- Adult / Pediatric | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-ACBB93C67D8C7730836188DD - Administration orientation
- Rapid IV push; 0.1 mg/mL prefilled syringe or 1 mg/mL vial depending on product; Rapid IV push
Source ID
H51-12C43C58A6A1ECAF4AC101D5 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-7DA565180AB3720D6AFEA5E1 - Key safety orientation
- Tachyarrhythmia, ischemia, anticholinergic effects.
Source ID
H51-5B5CFA5FD145698F8E04DD0E - Concentration errors between products.
Source ID
H51-86006802330132D87590EC95
- Tachyarrhythmia, ischemia, anticholinergic effects.
- Coverage path
- structured_local_snapshot
Source ID
H51-3489BD89218F8546A261685C - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-18EFE387E040C7DAEEFC2A8F - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-E3F84D7BBB3EAC58A5ACF879 - Search text
- Atropine Cardiovascular and vasoactive Antimuscarinic Symptomatic bradycardia Organophosphate/carbamate poisoning Competitively blocks muscarinic acetylcholine receptors and reduces parasympathetic cardiac effects. Adult / Pediatric | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | Patient- and indication-specific | See current package insert | IV push Rapid IV push; 0.1 mg/mL prefilled syringe or 1 mg/mL vial depending on product; Rapid IV push Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Tachyarrhythmia, ischemia, anticholinergic effects. Concentration errors between products. Structured GlobalRPh route snapshot
Source ID
H51-FDE529666AB88A30088DA6A0 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Atropine (opens in a new tab)
Source ID
H51-73A80C7740DC056B96C52BDE - Official access mode
- search
Source ID
H51-50B939FAB511294B4BD64603 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Atropine (opens in a new tab)
Source ID
H51-3B2E82BA83A86ADA99108CA5 - Official search query
- Atropine
Source ID
H51-1950C38C99DA4CEE1F8F2C64 - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-1779C7F8E0FA7FEE72796933
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- current_label_review_required
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for preparation, continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-B66D543A183BD6972E4AB79DSource IDH51-B74F5DE923217E4FBE416263 | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocolSource IDH51-434A1624C27F7F36755E2F4E | 0.1 mg/mL prefilled syringe or 1 mg/mL vial depending on productSource IDH51-8AC86BE85FBBEDD98EB8CDB5 | Rapid IV pushSource IDH51-210A930A08006D84C464490F | Use only when ordered and supported by current labeling or institutional policySource IDH51-7D94BF0EC18C30151C111534 | Slow administration at subtherapeutic doses may paradoxically worsen bradycardia. Toxicology dosing is much larger and symptom-driven.Source IDH51-570F633303B5B8AE356C1D5E |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-598A69E0492DBD2B988C786ESource IDH51-43E8C7CDE57C588EF8A58653 | Adult / PediatricSource IDH51-AB7DD6D0FC3DF5B325D4979A | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocolSource IDH51-3488AF3B5C5BC4B7C83E452D | Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocolSource IDH51-E3E762E2EB0DBBEBE1F918B0 | Patient- and indication-specificSource IDH51-684864B0F800E195CD7BDCFF | See current package insertSource IDH51-7E96D8A921B892CABC8C2827 | Rapid IV pushSource IDH51-F6DCBA30DD6009D80EF08F01 | Existing GlobalRPh IV push snapshotSource IDH51-C25D8EF29F68E5E9C1D0F21F | Use only when ordered and supported by current labeling or institutional policy Slow administration at subtherapeutic doses may paradoxically worsen bradycardia. Toxicology dosing is much larger and symptom-driven.Source IDH51-5C55F861052C6473DA398DFA |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- current_label_review_required
Source ID
H51-0477BB55EBEEFE0559101A6D - Summary
- Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
Source ID
H51-930231FCB65A41EF844B6201 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-2A555D2302F01E8433EB8690
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Symptomatic bradycardia
Source ID
H51-93FBE6913E301EE36DCDBEA4 - Organophosphate/carbamate poisoning
Source ID
H51-D32C90FFBF682ED3125D20C4
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Tachyarrhythmia, ischemia, anticholinergic effects.
Source ID
H51-37742F3349502F17B5AD45B1 - Concentration errors between products.
Source ID
H51-72C97BFA6B71929B1D0F470A
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Continuous ECG
Source ID
H51-3A29D348796AAA9EB9B921C1 - Heart rate, blood pressure, secretions in poisoning
Source ID
H51-775C5C6E7DBBF68096966B19
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
atropineSource ID
H51-24B1E39A4C0F1A45A902720EGeneric name
AtropineSource ID
H51-093082CD9DADA27D7910A044Class
Cardiovascular and vasoactiveSource ID
H51-9074F0841A1C434B1094FBC7Subclass
AntimuscarinicSource ID
H51-311121734CBD6A9B4B0851D7Summary
Antimuscarinic used as a rapid IV bolus for symptomatic bradycardia and selected cholinergic toxicity.Source ID
H51-607F9A379DC13C9AF613AC10Populations
- Adult
Source ID
H51-B7956B1DDC49E817B392BD19 - Pediatric
Source ID
H51-CBD5BB5804AA93077151BA1E
Evidence tier
IV push safety normalization - verify stocked productSource ID
H51-B33E6B78ECFF003133724357High alert
trueSource ID
H51-79A9377361E17C10BC117FF4Hazardous
falseSource ID
H51-4BFE8FF02A1B368F581B9B58Status
ActiveSource ID
H51-FF6D0A488FA92E0EDBEB7B0EReviewed
2026-08-29Source ID
H51-3D3DF61641F53AB3D64A67B1Version added
1.2Source ID
H51-F0EC03F80091F34777AABE17Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-9747ED9A10DCCAE0617D0CD2Source IDH51-527E5B86E05E8C69B112490D | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atropine (opens in a new tab)Source IDH51-59E9D910F4F2BE8161B97B7A | PrimarySource IDH51-9CC910746675F0D460219E2D |
Source IDH51-1F48229AE4E70CD8ECF58436Source IDH51-BFB2C199CCD30DFE4BE53E07 | legacy:autoSource IDH51-826EA7AE11F29EA84256DDB2 | LegacySource IDH51-739CF5DF3FDBD25E072427F0 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-FE8DCB268E4D5F2836AF668E - Audited on
- 2026-08-30
Source ID
H51-AF5929A90854AF6A3775F9BC - Level
- amber
Source ID
H51-3DDD8CA134E6477CB5F86AA4 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-380593AE30825DF17BD5A513 - Exact current label candidate
- false
Source ID
H51-CDD698B9301B0363F433F632 - Numeric support ratio
- 0
Source ID
H51-E45CF05AEB2E554DF532E88A - Reference url count
- 1
Source ID
H51-B9E49BBACDC4A5AC0755A855 - Broken reference count
- 0
Source ID
H51-A29EBD8CB6A8AAC58972FF5C - Point of use confirmation required
- true
Source ID
H51-4EDAD4DC43A1D1BA0CCD3513 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-324D18A047122A3F3405501D - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atropine (opens in a new tab)
Source ID
H51-31E38CAAF3CBCA8F4A4A9A4C
Dosing source fields
Id
atropineSource ID
H51-6CBBDAB733DB25DF858E88FDGeneric name
AtropineSource ID
H51-32C8F9F209D31950F884BD02Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-63FA9CCCFA5FB83B53D4B744Package insert
- Query name
- Atropine
Source ID
H51-B256B90382D16A032E0332C6 - Product and route must match
- true
Source ID
H51-B7608FF14FD0949321E059F2 - Live current label enabled
- false
Source ID
H51-B80042B6FE97CD95C153677E - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-AC06224D15D6AF64E5C063DF - Direct official label access enabled
- true
Source ID
H51-B6182556067CAABDDEEDBD7D - Outbound server request required
- false
Source ID
H51-4EBF78BE32B5B6CA3351C043 - Local summary status
- not_bundled
Source ID
H51-C6FB620A9BC422039C4CEC52
Clinical review
- Locally normalized
- false
Source ID
H51-241A8176B3171619C257EBC3 - Reviewed
- 2026-08-29
Source ID
H51-AE2699E12D597603071B47F2 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-71E6120B963CDFDA6086E462
Clinical release verification
- Audit version
- 3.4
Source ID
H51-F961C5FDAF11DFC4E29336F3 - Audited on
- 2026-08-30
Source ID
H51-8721E9824118961678700356 - Level
- amber
Source ID
H51-46AC409802AAE57EE0443E82 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-6F8B33DF49C94E7744AAAB48 - Exact current label candidate
- false
Source ID
H51-D908362C9FAAEE070BE482AB - Numeric support ratio
- 0
Source ID
H51-0E187ECE4E01F683976E9E96 - Reference url count
- 1
Source ID
H51-286A36A51B4FE74BECD6DDA1 - Broken reference count
- 0
Source ID
H51-851A2308337CEDB0BFAF7B00 - Point of use confirmation required
- true
Source ID
H51-5261DA3803D42D1FD4A111E3 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-FF1503597B8611E268C2A05F - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atropine (opens in a new tab)
Source ID
H51-8B2FD2D44EAF15EE10EDD5B6
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- atropine
Source ID
H51-282692C77BAFAD1FA6EE9590 - Name
- Atropine
Source ID
H51-19E450B85EE36F25DF788EA4 - Therapeutic class
- Cardiovascular and vasoactive
Source ID
H51-98C29289494BAE193AF8690A - Review version
- 3.1
Source ID
H51-7F92BACB8D5E9ECE8220C77F - Review date
- 2026-08-30
Source ID
H51-11425268F99CB53F128B2D9A - Release status
- no_released_dilution_current_label_review_required
Source ID
H51-FB8F5466A31EE4175FCFED81 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-533BC1C49F7561CEEE8172CF - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-B2BE9EC4353E06AE13252C2B
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-D50EA608ACAF553027F05878 - Reconstitution concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-E71BE88EEB7CC3720BDA2523 - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-EE1A810AF0559854EB8027B0 - Appropriate standardized containers
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-31CA6898607DE95BC5C1C383 - Adult dosing range
- Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol
Source ID
H51-61F8FB1F2988C30D9854EB16 - Pediatric dosing range
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source. | existing_route_snapshots: route: IV push | population: Adult / Pediatric | indication: Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | dose: Adult bradycardia: 1 mg every 3 to 5 minutes to algorithm maximum; pediatric dose per resuscitation protocol | interval: Patient- and indication-specific | duration: See current package insert | administration: Rapid IV push | source_level: Existing GlobalRPh IV push snapshot | notes: Use only when ordered and supported by current labeling or institutional policy Slow administration at subtherapeutic doses may paradoxically worsen bradycardia. Toxicology dosing is much larger and symptom-driven. | warnings: Tachyarrhythmia, ischemia, anticholinergic effects. | Concentration errors between products. | monitoring: Continuous ECG | Heart rate, blood pressure, secretions in poisoning | populations: Adult | Pediatric | evidence_tier: IV push safety normalization - verify stocked product | high_alert: true | hazardous: false | status: Active | reviewed: 2026-08-29 | version_added: 1.2 | sources: label: DailyMed label search | url: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atropine | kind: Primary | label: GlobalRPh legacy IV dilution monograph | url: legacy:auto | kind: Legacy
Source ID
H51-C67D01D7BE9B184B1543B7C4 - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-AC77B385C191522312CBF4C2 - Infusion time
- Rapid IV push
Source ID
H51-6D4ADCE9337A7CE46D6EFF48 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-703178A3C43E147CFD7697FF - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-1B704B47EC3C5EBF903E86FD - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atropine (opens in a new tab)
Source ID
H51-6E8F8B4F6EB64B50E14141BB
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-305A3BDB8178B5D88EB741AE
- Reconstitution concentration
- Primary
- not_found
Source ID
H51-462F2C36EFB9A88C26E843AE
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-88AEB6D90387AD30970020FF
- Appropriate standardized containers
- Primary
- not_found
Source ID
H51-0A03A345BAEBA42B0ABD31CC
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-C2DF6C3F8510EDE7DBC6AA9A
- Pediatric dosing range
- Primary
- existing_record_text
Source ID
H51-49371B54039D92988A8DD524
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-2E2B740BFB24EFF602C72ADC
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-4B0BF0FFE71EABDF96D8790F
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-98B43C468D34910077E7CA39
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-02D8876830C07DBADCD1921F
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-B55BD73F996D3A775D284C7B - Guide generation allowed
- true
Source ID
H51-A154A168188E4A1B8D9B916B
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-A4478AD8FF8DC48F0D500AD8 - Guide generation allowed
- false
Source ID
H51-9D4D0C496513A1002EA7FA22
- Neonatal
- Applicability
- not_established
Source ID
H51-118BB30A7AB9A5EDEAD2E04B - Guide generation allowed
- false
Source ID
H51-AE678CC0E8082F93790826AF
- Route presence
- Structured dilution
- false
Source ID
H51-597A7B2D66DC6EE7E37A1EAE - Iv push
- true
Source ID
H51-0CE15CC1538DE324FD590B72 - Continuous infusion
- false
Source ID
H51-D3CA0A11935F08DFC080145E - Pediatric source
- true
Source ID
H51-B4D10C0BE90DAB8BB402D0DE - Neonatal source
- false
Source ID
H51-3D1975B9A28E836CF7F98426
- Legacy reference
- Status
- not_available
Source ID
H51-02FB57DDB03B1A62C1F4C066
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-A392CB897407A88EB56CF689
- Source files
- catalog.json
Source ID
H51-C08A8D0414924914280E8A58 - dosing.json
Source ID
H51-4B005DCB0838B94405EC7575 - new-in-v1.2.json
Source ID
H51-2873574D40208C3DB9A9CA9F
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-8FDD88913ABC54A4B716CDF8
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-24B1E39A4C0F1A45A902720E | catalog.json/records/28/id | Historical; current review incomplete |
H51-093082CD9DADA27D7910A044 | catalog.json/records/28/generic_name | Historical; current review incomplete |
H51-9074F0841A1C434B1094FBC7 | catalog.json/records/28/class | Historical; current review incomplete |
H51-311121734CBD6A9B4B0851D7 | catalog.json/records/28/subclass | Historical; current review incomplete |
H51-607F9A379DC13C9AF613AC10 | catalog.json/records/28/summary | Historical; current review incomplete |
H51-93FBE6913E301EE36DCDBEA4 | catalog.json/records/28/common_uses/0 | Historical; current review incomplete |
H51-D32C90FFBF682ED3125D20C4 | catalog.json/records/28/common_uses/1 | Historical; current review incomplete |
H51-B66D543A183BD6972E4AB79D | catalog.json/records/28/iv_push/0 | Historical; current review incomplete |
H51-B74F5DE923217E4FBE416263 | catalog.json/records/28/iv_push/0/population | Historical; current review incomplete |
H51-434A1624C27F7F36755E2F4E | catalog.json/records/28/iv_push/0/dose_scope | Historical; current review incomplete |
H51-8AC86BE85FBBEDD98EB8CDB5 | catalog.json/records/28/iv_push/0/concentration | Historical; current review incomplete |
H51-210A930A08006D84C464490F | catalog.json/records/28/iv_push/0/rate | Historical; current review incomplete |
H51-7D94BF0EC18C30151C111534 | catalog.json/records/28/iv_push/0/status | Historical; current review incomplete |
H51-570F633303B5B8AE356C1D5E | catalog.json/records/28/iv_push/0/notes | Historical; current review incomplete |
H51-37742F3349502F17B5AD45B1 | catalog.json/records/28/warnings/0 | Historical; current review incomplete |
H51-72C97BFA6B71929B1D0F470A | catalog.json/records/28/warnings/1 | Historical; current review incomplete |
H51-3A29D348796AAA9EB9B921C1 | catalog.json/records/28/monitoring/0 | Historical; current review incomplete |
H51-775C5C6E7DBBF68096966B19 | catalog.json/records/28/monitoring/1 | Historical; current review incomplete |
H51-B7956B1DDC49E817B392BD19 | catalog.json/records/28/populations/0 | Historical; current review incomplete |
H51-CBD5BB5804AA93077151BA1E | catalog.json/records/28/populations/1 | Historical; current review incomplete |
H51-B33E6B78ECFF003133724357 | catalog.json/records/28/evidence_tier | Historical; current review incomplete |
H51-79A9377361E17C10BC117FF4 | catalog.json/records/28/high_alert | Historical; current review incomplete |
H51-4BFE8FF02A1B368F581B9B58 | catalog.json/records/28/hazardous | Historical; current review incomplete |
H51-FF6D0A488FA92E0EDBEB7B0E | catalog.json/records/28/status | Historical; current review incomplete |
H51-3D3DF61641F53AB3D64A67B1 | catalog.json/records/28/reviewed | Historical; current review incomplete |
H51-F0EC03F80091F34777AABE17 | catalog.json/records/28/version_added | Historical; current review incomplete |
H51-9747ED9A10DCCAE0617D0CD2 | catalog.json/records/28/sources/0 | Historical; current review incomplete |
H51-527E5B86E05E8C69B112490D | catalog.json/records/28/sources/0/label | Historical; current review incomplete |
H51-59E9D910F4F2BE8161B97B7A | catalog.json/records/28/sources/0/url | Historical; current review incomplete |
H51-9CC910746675F0D460219E2D | catalog.json/records/28/sources/0/kind | Historical; current review incomplete |
H51-1F48229AE4E70CD8ECF58436 | catalog.json/records/28/sources/1 | Historical; current review incomplete |
H51-BFB2C199CCD30DFE4BE53E07 | catalog.json/records/28/sources/1/label | Historical; current review incomplete |
H51-826EA7AE11F29EA84256DDB2 | catalog.json/records/28/sources/1/url | Historical; current review incomplete |
H51-739CF5DF3FDBD25E072427F0 | catalog.json/records/28/sources/1/kind | Historical; current review incomplete |
H51-556EEE529A986BD0317665F9 | catalog.json/records/28/legacy_title | Historical; current review incomplete |
H51-FE8DCB268E4D5F2836AF668E | catalog.json/records/28/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-AF5929A90854AF6A3775F9BC | catalog.json/records/28/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-3DDD8CA134E6477CB5F86AA4 | catalog.json/records/28/clinical_release_verification/level | Historical; current review incomplete |
H51-380593AE30825DF17BD5A513 | catalog.json/records/28/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-CDD698B9301B0363F433F632 | catalog.json/records/28/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-A6534EEA563028ACCB242EEF | catalog.json/records/28/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-755DA8A154C91AC454289405 | catalog.json/records/28/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-E45CF05AEB2E554DF532E88A | catalog.json/records/28/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-B9E49BBACDC4A5AC0755A855 | catalog.json/records/28/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-A29EBD8CB6A8AAC58972FF5C | catalog.json/records/28/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-4EDAD4DC43A1D1BA0CCD3513 | catalog.json/records/28/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-324D18A047122A3F3405501D | catalog.json/records/28/clinical_release_verification/note | Historical; current review incomplete |
H51-31E38CAAF3CBCA8F4A4A9A4C | catalog.json/records/28/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-6CBBDAB733DB25DF858E88FD | dosing.json/records/28/id | Historical; current review incomplete |
H51-32C8F9F209D31950F884BD02 | dosing.json/records/28/generic_name | Historical; current review incomplete |
H51-63FA9CCCFA5FB83B53D4B744 | dosing.json/records/28/coverage_status | Historical; current review incomplete |
H51-B256B90382D16A032E0332C6 | dosing.json/records/28/package_insert/query_name | Historical; current review incomplete |
H51-804A43CF2E99D75526711A48 | dosing.json/records/28/package_insert/preferred_setid | Historical; current review incomplete |
H51-B7608FF14FD0949321E059F2 | dosing.json/records/28/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-B80042B6FE97CD95C153677E | dosing.json/records/28/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-AC06224D15D6AF64E5C063DF | dosing.json/records/28/package_insert/source_priority | Historical; current review incomplete |
H51-B6182556067CAABDDEEDBD7D | dosing.json/records/28/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-4EBF78BE32B5B6CA3351C043 | dosing.json/records/28/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-C6FB620A9BC422039C4CEC52 | dosing.json/records/28/package_insert/local_summary_status | Historical; current review incomplete |
H51-0477BB55EBEEFE0559101A6D | dosing.json/records/28/renal/classification | Historical; current review incomplete |
H51-930231FCB65A41EF844B6201 | dosing.json/records/28/renal/summary | Historical; current review incomplete |
H51-2A555D2302F01E8433EB8690 | dosing.json/records/28/renal/method_note | Historical; current review incomplete |
H51-598A69E0492DBD2B988C786E | dosing.json/records/28/existing_route_snapshots/0 | Historical; current review incomplete |
H51-43E8C7CDE57C588EF8A58653 | dosing.json/records/28/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-AB7DD6D0FC3DF5B325D4979A | dosing.json/records/28/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-3488AF3B5C5BC4B7C83E452D | dosing.json/records/28/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-E3E762E2EB0DBBEBE1F918B0 | dosing.json/records/28/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-684864B0F800E195CD7BDCFF | dosing.json/records/28/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-7E96D8A921B892CABC8C2827 | dosing.json/records/28/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-F6DCBA30DD6009D80EF08F01 | dosing.json/records/28/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-C25D8EF29F68E5E9C1D0F21F | dosing.json/records/28/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-5C55F861052C6473DA398DFA | dosing.json/records/28/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-241A8176B3171619C257EBC3 | dosing.json/records/28/clinical_review/locally_normalized | Historical; current review incomplete |
H51-AE2699E12D597603071B47F2 | dosing.json/records/28/clinical_review/reviewed | Historical; current review incomplete |
H51-71E6120B963CDFDA6086E462 | dosing.json/records/28/clinical_review/status | Historical; current review incomplete |
H51-F961C5FDAF11DFC4E29336F3 | dosing.json/records/28/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-8721E9824118961678700356 | dosing.json/records/28/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-46AC409802AAE57EE0443E82 | dosing.json/records/28/clinical_release_verification/level | Historical; current review incomplete |
H51-6F8B33DF49C94E7744AAAB48 | dosing.json/records/28/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-D908362C9FAAEE070BE482AB | dosing.json/records/28/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-DEA2192E46D4FBE37B7A347D | dosing.json/records/28/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-E897C00B6DE854BA8855F329 | dosing.json/records/28/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-0E187ECE4E01F683976E9E96 | dosing.json/records/28/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-286A36A51B4FE74BECD6DDA1 | dosing.json/records/28/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-851A2308337CEDB0BFAF7B00 | dosing.json/records/28/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-5261DA3803D42D1FD4A111E3 | dosing.json/records/28/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-FF1503597B8611E268C2A05F | dosing.json/records/28/clinical_release_verification/note | Historical; current review incomplete |
H51-8B2FD2D44EAF15EE10EDD5B6 | dosing.json/records/28/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-920FFC12C4B68479CDD1ADCA | first-look-v5.1.json/records/28/id | Historical; current review incomplete |
H51-D772F077326FFBC2C803F602 | first-look-v5.1.json/records/28/generic_name | Historical; current review incomplete |
H51-91DB86569C5DB3CEA013C4A7 | first-look-v5.1.json/records/28/class | Historical; current review incomplete |
H51-F65FF3AC679FC61670213835 | first-look-v5.1.json/records/28/subclass | Historical; current review incomplete |
H51-35CC4A63A23EE81190C39804 | first-look-v5.1.json/records/28/primary_uses/0 | Historical; current review incomplete |
H51-E1C78AE871B082FB18381A35 | first-look-v5.1.json/records/28/primary_uses/1 | Historical; current review incomplete |
H51-72A6BA0355334CC92475B0A1 | first-look-v5.1.json/records/28/mechanism | Historical; current review incomplete |
H51-E9BA516C22D499A915AD0676 | first-look-v5.1.json/records/28/mechanism_level | Historical; current review incomplete |
H51-ACBB93C67D8C7730836188DD | first-look-v5.1.json/records/28/basic_dosing_orientation | Historical; current review incomplete |
H51-12C43C58A6A1ECAF4AC101D5 | first-look-v5.1.json/records/28/administration_orientation | Historical; current review incomplete |
H51-7DA565180AB3720D6AFEA5E1 | first-look-v5.1.json/records/28/renal_and_population_orientation | Historical; current review incomplete |
H51-5B5CFA5FD145698F8E04DD0E | first-look-v5.1.json/records/28/key_safety_orientation/0 | Historical; current review incomplete |
H51-86006802330132D87590EC95 | first-look-v5.1.json/records/28/key_safety_orientation/1 | Historical; current review incomplete |
H51-3489BD89218F8546A261685C | first-look-v5.1.json/records/28/coverage_path | Historical; current review incomplete |
H51-18EFE387E040C7DAEEFC2A8F | first-look-v5.1.json/records/28/coverage_path_label | Historical; current review incomplete |
H51-A58550B2BCC20D572D0BCC9B | first-look-v5.1.json/records/28/official_label_url | Historical; current review incomplete |
H51-6864067BE406F64276ABE625 | first-look-v5.1.json/records/28/legacy_title | Historical; current review incomplete |
H51-E3F84D7BBB3EAC58A5ACF879 | first-look-v5.1.json/records/28/review_note | Historical; current review incomplete |
H51-FDE529666AB88A30088DA6A0 | first-look-v5.1.json/records/28/search_text | Historical; current review incomplete |
H51-73A80C7740DC056B96C52BDE | first-look-v5.1.json/records/28/official_search_url | Historical; current review incomplete |
H51-50B939FAB511294B4BD64603 | first-look-v5.1.json/records/28/official_access_mode | Historical; current review incomplete |
H51-3B2E82BA83A86ADA99108CA5 | first-look-v5.1.json/records/28/official_access_url | Historical; current review incomplete |
H51-1950C38C99DA4CEE1F8F2C64 | first-look-v5.1.json/records/28/official_search_query | Historical; current review incomplete |
H51-1779C7F8E0FA7FEE72796933 | first-look-v5.1.json/records/28/official_access_reason | Historical; current review incomplete |
H51-282692C77BAFAD1FA6EE9590 | preparation-assessments-v3.8.json/28/id | Historical; current review incomplete |
H51-19E450B85EE36F25DF788EA4 | preparation-assessments-v3.8.json/28/name | Historical; current review incomplete |
H51-3F3185CE54A5C1AF6C499165 | preparation-assessments-v3.8.json/28/brands | Historical; current review incomplete |
H51-98C29289494BAE193AF8690A | preparation-assessments-v3.8.json/28/therapeutic_class | Historical; current review incomplete |
H51-7F92BACB8D5E9ECE8220C77F | preparation-assessments-v3.8.json/28/review_version | Historical; current review incomplete |
H51-11425268F99CB53F128B2D9A | preparation-assessments-v3.8.json/28/review_date | Historical; current review incomplete |
H51-FB8F5466A31EE4175FCFED81 | preparation-assessments-v3.8.json/28/release_status | Historical; current review incomplete |
H51-533BC1C49F7561CEEE8172CF | preparation-assessments-v3.8.json/28/market_status/status | Historical; current review incomplete |
H51-B2BE9EC4353E06AE13252C2B | preparation-assessments-v3.8.json/28/market_status/basis | Historical; current review incomplete |
H51-D50EA608ACAF553027F05878 | preparation-assessments-v3.8.json/28/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-E71BE88EEB7CC3720BDA2523 | preparation-assessments-v3.8.json/28/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-EE1A810AF0559854EB8027B0 | preparation-assessments-v3.8.json/28/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-31CA6898607DE95BC5C1C383 | preparation-assessments-v3.8.json/28/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-61F8FB1F2988C30D9854EB16 | preparation-assessments-v3.8.json/28/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-C67D01D7BE9B184B1543B7C4 | preparation-assessments-v3.8.json/28/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-AC77B385C191522312CBF4C2 | preparation-assessments-v3.8.json/28/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-6D4ADCE9337A7CE46D6EFF48 | preparation-assessments-v3.8.json/28/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-703178A3C43E147CFD7697FF | preparation-assessments-v3.8.json/28/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-1D4DCA3DA913994759F4D164 | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-F00044921E0F5346538F0E96 | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-22453BB5094B18AA798A98ED | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-C5D6864193D20CD22E41983D | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-1B704B47EC3C5EBF903E86FD | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-6E8F8B4F6EB64B50E14141BB | preparation-assessments-v3.8.json/28/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-305A3BDB8178B5D88EB741AE | preparation-assessments-v3.8.json/28/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-462F2C36EFB9A88C26E843AE | preparation-assessments-v3.8.json/28/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-88AEB6D90387AD30970020FF | preparation-assessments-v3.8.json/28/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-0A03A345BAEBA42B0ABD31CC | preparation-assessments-v3.8.json/28/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-C2DF6C3F8510EDE7DBC6AA9A | preparation-assessments-v3.8.json/28/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-49371B54039D92988A8DD524 | preparation-assessments-v3.8.json/28/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-2E2B740BFB24EFF602C72ADC | preparation-assessments-v3.8.json/28/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-4B0BF0FFE71EABDF96D8790F | preparation-assessments-v3.8.json/28/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-98B43C468D34910077E7CA39 | preparation-assessments-v3.8.json/28/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-02D8876830C07DBADCD1921F | preparation-assessments-v3.8.json/28/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-B55BD73F996D3A775D284C7B | preparation-assessments-v3.8.json/28/population_applicability/adult/applicability | Historical; current review incomplete |
H51-A154A168188E4A1B8D9B916B | preparation-assessments-v3.8.json/28/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-A4478AD8FF8DC48F0D500AD8 | preparation-assessments-v3.8.json/28/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-9D4D0C496513A1002EA7FA22 | preparation-assessments-v3.8.json/28/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-118BB30A7AB9A5EDEAD2E04B | preparation-assessments-v3.8.json/28/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-AE678CC0E8082F93790826AF | preparation-assessments-v3.8.json/28/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-597A7B2D66DC6EE7E37A1EAE | preparation-assessments-v3.8.json/28/route_presence/structured_dilution | Historical; current review incomplete |
H51-0CE15CC1538DE324FD590B72 | preparation-assessments-v3.8.json/28/route_presence/iv_push | Historical; current review incomplete |
H51-D3CA0A11935F08DFC080145E | preparation-assessments-v3.8.json/28/route_presence/continuous_infusion | Historical; current review incomplete |
H51-B4D10C0BE90DAB8BB402D0DE | preparation-assessments-v3.8.json/28/route_presence/pediatric_source | Historical; current review incomplete |
H51-3D1975B9A28E836CF7F98426 | preparation-assessments-v3.8.json/28/route_presence/neonatal_source | Historical; current review incomplete |
H51-02FB57DDB03B1A62C1F4C066 | preparation-assessments-v3.8.json/28/legacy_reference/status | Historical; current review incomplete |
H51-A392CB897407A88EB56CF689 | preparation-assessments-v3.8.json/28/label_resolution/status | Historical; current review incomplete |
H51-C08A8D0414924914280E8A58 | preparation-assessments-v3.8.json/28/source_files/0 | Historical; current review incomplete |
H51-4B005DCB0838B94405EC7575 | preparation-assessments-v3.8.json/28/source_files/1 | Historical; current review incomplete |
H51-2873574D40208C3DB9A9CA9F | preparation-assessments-v3.8.json/28/source_files/2 | Historical; current review incomplete |
H51-8FDD88913ABC54A4B716CDF8 | preparation-assessments-v3.8.json/28/clinical_release_note | Historical; current review incomplete |